(CPRX) CPP-115 Suppresses IS in the Rat Multiple-hit Model

  • Share
    Share Video

  • Add
  • More
    Report this video as:
0 0
You have already voted for this video.
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Catalyst Pharmaceutical Partners Inc - C...
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Catalyst Pharmaceutical Partners Inc - CPRX - reported that a poster presentation about the company’s next-generation GABA aminotransferase inhibitor, CPP-115, will be made on Dec. 3rd, 2011 at the American Epilepsy Society’s 65th Annual Meeting. The poster describes a study conclusions, demonstrating that CPP-115 suppresses infantile spasms in the rat multiple-hit model. Infantile spasm is a rare seizure disorder of infancy and early childhood. Characteristic features of Infantile spasms include myoclonic seizures, hypsarrhythmia (abnormal, chaotic electroencephalogram), and mental retardation. Catalyst Pharmaceutical is a development-stage biopharmaceutical company focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of addiction and epilepsy. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire**** publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at *******www.crwenewswire****/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire**** report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
Categories:
Related